Purchase Order 75N95025P00411
- Not listed
- The National Institute on Drug Abuse (NIDA) awarded a $1.35 million firm fixed-price purchase order to Bruker Biospin Corp on September 25, 2024, for a service contract renewal covering maintenance and support of multiple Bruker Magnetic Resonance Imaging (MRI) systems. The contract, with an ultimate completion date of September 24, 2029, will be performed at the contractor's location in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC and a specialized...
- This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $145,700.00 contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. The award has an ultimate completion date of May 31, 2019 and was not set aside for any...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments and equipment. The $700,000.00 firm fixed-price purchase order was awarded on September 27, 2016 with a period of performance through June 30, 2017. The contract did not have a set-aside designation. Based on the vendor description, Bruker Biospin Corp has a history of providing nuclear magnetic resonance (NMR)...
- This is a $80,095.65 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp for the renewal of yearly preventive-maintenance services for a nuclear magnetic resonance (NMR) spectrometer. This contract is not associated with any set-aside programs. Bruker Biospin Corp, a subsidiary of Bruker Corporation, is a manufacturer of scientific instruments that provides specialized equipment, maintenance, and support services to...
- This firm fixed-price purchase order for $448,560.63 was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Bruker Biospin Corp. to deliver one 400 megahertz Nuclear Magnetic Resonance Spectrometer. The spectrometer will support the National Center for Advancing Translational Sciences and must be delivered within five months to the specified National Institutes of Health location in Rockville, Maryland. The original...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a manufacturer of scientific instruments, on April 26, 2017. The contract, valued at $150,000.00, does not have a set-aside designation and is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. Bruker Biospin Corp is a manufacturer that provides specialized equipment and...
- This firm fixed-price purchase order for $22,695 awards Bruker Biospin Corporation the decommissioning and packing of a Bruker 400 MHz Avance NEO nuclear magnetic resonance (NMR) spectrometer and room temperature probe owned by the National Institutes of Health's National Center for Advancing Translational Sciences. As the sole source manufacturer of the proprietary NMR equipment, Bruker must perform the work to maintain warranty and ensure functionality of the components. The award is...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The $76,869.48 firm fixed-price purchase order is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and support services. The award does not have a set-aside designation. Bruker Biospin Corp has a history of providing specialized equipment and services to various U.S....
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $587,061 firm fixed price purchase order to Bruker Biospin Corp. to acquire an Avance Neo 700 MHz NMR console compatible with an existing 700 MHz spectrometer located at NIH's campus in Bethesda, Maryland. The solicitation sought quotes for the NMR equipment upgrade by September 5, 2023, with delivery and installation within six to nine months of award. Evaluation factors included...
- This is a $75,000.00 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of scientific instruments and equipment, specifically nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers, along with...
On September 19, 2025, the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded Bruker Biospin Corp a firm fixed-price purchase order valued at $59,015 for the installation of NMR console and peripheral equipment for a Bruker 400 MHz Avance NEO Ascend NMR System. The installation will be performed at the Analytical Chemistry Core facility in Potomac, Maryland, with a completion deadline of December 31, 2025. This was a sole-source procurement that did not utilize any small business set-aside, reflecting the specialized nature of the equipment and the requirement for proprietary Bruker field service expertise to ensure proper installation while maintaining equipment warranties. Bruker Biospin Corp, headquartered in Billerica, Massachusetts, is a subsidiary of Bruker Scientific LLC and specializes in the design, manufacture, and distribution of advanced scientific instrumentation, particularly NMR spectrometers and related analytical technologies. The company has an established track record of providing specialized scientific equipment, installation services, and maintenance support to federal agencies, particularly the NIH and its various institutes. This contract supports NIDA's research capabilities by enabling complex molecular analysis, structure validation, purity assessment, and protein-ligand binding studies critical to the institute's drug abuse research mission.